Merck & Co Inc [NYSE: MRK] price surged by 1.21 percent to reach at $1.38.
The one-year MRK stock forecast points to a potential upside of 18.79. The average equity rating for MRK stock is currently 1.44, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Merck & Co Inc [MRK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRK shares is $141.85 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRK stock is a recommendation set at 1.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Societe Generale have made an estimate for Merck & Co Inc shares, keeping their opinion on the stock as Sell, with their previous recommendation back on March 11, 2024. While these analysts kept the previous recommendation, TD Cowen raised their target price from $125 to $135. The new note on the price target was released on January 04, 2024, representing the official price target for Merck & Co Inc stock. Previously, the target price had yet another raise to $115, while Deutsche Bank analysts kept a Buy rating on MRK stock.
The Average True Range (ATR) for Merck & Co Inc is set at 3.50, with the Price to Sales ratio for MRK stock in the period of the last 12 months amounting to 4.70. The Price to Book ratio for the last quarter was 7.23, with the Price to Cash per share for the same quarter was set at 2.25. Price to Free Cash Flow for MRK in the course of the last twelve months was 26.43 with Quick ratio for the last quarter at 0.99.
MRK Stock Performance Analysis:
Merck & Co Inc [MRK] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.03. With this latest performance, MRK shares dropped by -8.46% in over the last four-week period, additionally sinking by -8.85% over the last 6 months – not to mention a rise of 8.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MRK stock in for the last two-week period is set at 32.93, with the RSI for the last a single of trading hit 30.54, and the three-weeks RSI is set at 35.31 for Merck & Co Inc [MRK]. The present Moving Average for the last 50 days of trading for this stock 126.93, while it was recorded at 117.04 for the last single week of trading, and 120.11 for the last 200 days.
Insight into Merck & Co Inc Fundamentals:
Merck & Co Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.99 and a Current Ratio set at 1.25.
Merck & Co Inc [MRK] Institutonal Ownership Details
The top three institutional holders of MRK stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in MRK stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in MRK stock with ownership which is approximately 5.1238%.
